Overview

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
2019-03-06
Target enrollment:
Participant gender:
Summary
This is a study to assess the long-term safety, tolerability, and efficacy of bimekizumab.
Phase:
Phase 2
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.